Crushed buprenorphine or buprenorphine-naloxone for opioid dependency a review of the clinical effectiveness and guidelines
The purpose of this report is to review the clinical effectiveness and safety of sublingual crushed buprenorphine or crushed buprenorphine-naloxone for treating opioid dependency, compared to the uncrushed products, and to review the evidence-based guidelines regarding the administration of crushed...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, 18 July 2016
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to review the clinical effectiveness and safety of sublingual crushed buprenorphine or crushed buprenorphine-naloxone for treating opioid dependency, compared to the uncrushed products, and to review the evidence-based guidelines regarding the administration of crushed buprenorphine or crushed buprenorphine-naloxone |
|---|---|
| Item Description: | Caption title. - "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (12 pages) illustrations |